For its role in APP processing and Aβ generation, BACE1 is a central actor in the pathogenesis of Alzheimer's disease, and β-secretase inhibition has become a therapeutic goal. The gene discussed is BACE1; the disease is early-onset autosomal dominant Alzheimer disease.